These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 3038389)

  • 1. Changes in arterial distensibility produced by converting enzyme inhibitors in hypertensive humans.
    Safar ME; London GM; Safavian A; St Laurent ; Pannier B
    Clin Exp Hypertens A; 1987; 9(2-3):289-95. PubMed ID: 3038389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of acute and chronic angiotensin-converting enzyme inhibition on large arteries in human hypertension.
    Simon AC; Levenson JA; Bouthier J; Maarek B; Safar ME
    J Cardiovasc Pharmacol; 1985; 7 Suppl 1():S45-51. PubMed ID: 2580176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Captopril-induced changes in large arteries in essential hypertension.
    Simon AC; Levenson JA; Bouthier JL; Safar ME
    Am J Med; 1984 May; 76(5B):71-5. PubMed ID: 6328988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative effects of captopril and isosorbide dinitrate on the arterial wall of hypertensive human brachial arteries.
    Safar ME; Laurent S; Bouthier JA; London GM
    J Cardiovasc Pharmacol; 1986; 8(6):1257-61. PubMed ID: 2434755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The renin-angiotensin system and large arteries in the hypertensive patient].
    Bouthier J; Hugue C; Asmar R; Simon A; Safar M
    Ann Cardiol Angeiol (Paris); 1985 Dec; 34(10):693-6. PubMed ID: 3004317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arterial hemodynamics in human hypertension. Effects of angiotensin converting enzyme inhibition.
    Ting CT; Yang TM; Chen JW; Chang MS; Yin FC
    Hypertension; 1993 Dec; 22(6):839-46. PubMed ID: 8244515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-invasive determination of arterial diameter and distensibility by echo-tracking techniques in hypertension.
    Hayoz D; Tardy Y; Perret F; Waeber B; Meister JJ; Brunner HR
    J Hypertens Suppl; 1992 Jul; 10(5):S95-100. PubMed ID: 1328567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of ramipril on arterial hemodynamics.
    Benetos A; Vasmant D; Thiéry P; Safar M
    J Cardiovasc Pharmacol; 1991; 18 Suppl 2():S153-6. PubMed ID: 1725030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term effects of angiotensin-converting enzyme inhibition on the arterial wall of adult spontaneously hypertensive rats.
    Levy BI; Michel JB; Salzmann JL; Poitevin P; Devissaguet M; Scalbert E; Safar ME
    Am J Cardiol; 1993 Jun; 71(17):8E-16E. PubMed ID: 8328370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arterial structure in hypertension and the effects of angiotensin converting enzyme inhibition.
    Safar ME; Levy BI; London GM
    J Hypertens Suppl; 1992 Jul; 10(5):S51-7. PubMed ID: 1403234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose optimization study of arterial changes associated with angiotensin converting enzyme inhibition in hypertension.
    Asmar RG; Iannascoli F; Benetos A; Safar ME
    J Hypertens Suppl; 1992 Jul; 10(5):S13-9. PubMed ID: 1403229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance and conduit arteries following converting enzyme inhibition in hypertension.
    Safar ME; van Bortel LM; Struijker-Boudier HA
    J Vasc Res; 1997; 34(2):67-81. PubMed ID: 9167639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemodynamic effects of angiotensin-converting enzyme inhibitors in essential hypertension: a review.
    Fitzpatrick MA; Julius S
    J Cardiovasc Pharmacol; 1985; 7 Suppl 1():S35-9. PubMed ID: 2580174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vessel wall properties of large arteries in hypertension and effect of antihypertensive treatment.
    Van Bortel LM; Kool MJ
    Can J Cardiol; 1994 Nov; 10 Suppl D():37D-40D. PubMed ID: 7954040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antihypertensive effects and arterial haemodynamic alterations during angiotensin converting enzyme inhibition.
    London GM; Pannier B; Vicaut E; Guérin AP; Marchais SJ; Safar ME; Cuche JL
    J Hypertens; 1996 Sep; 14(9):1139-46. PubMed ID: 8986916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of angiotensin-converting enzyme inhibitors and sclerotherapy on portal hemodynamics in patients with portal hypertension.
    Nasr AA; el-Hak NG; Settein ME; Khafagy MA; Tadros MT
    Hepatogastroenterology; 2000; 47(33):795-806. PubMed ID: 10919035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Graded regional vasodilation with converting enzyme inhibitors in conscious spontaneously hypertensive rats.
    Lappe RW; Todt JA; Wendt RL
    J Pharmacol Exp Ther; 1985 Dec; 235(3):651-6. PubMed ID: 3001271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of chronic converting enzyme inhibition on the structure and function of large arteries in the rat.
    Levy BI; Michel JB; Salzmann JL; Devissaguet M; Camilleri JP; Safar ME
    Clin Exp Hypertens A; 1989; 11 Suppl 2():487-98. PubMed ID: 2605798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular effects of perindopril: from experimental to clinical investigation.
    Scalbert E; Levy B; Desche P; Devissaguet M; Safar ME
    J Cardiovasc Pharmacol; 1991; 18 Suppl 7():S25-32. PubMed ID: 1725197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal hemodynamic effects of nonhypotensive doses of angiotensin-converting enzyme inhibitors in hypertension and heart failure rats.
    Nelissen-Vrancken HJ; Struijker-Boudier HA; Smits JF
    J Cardiovasc Pharmacol; 1992 Feb; 19(2):163-8. PubMed ID: 1376783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.